Sanrovax is a biotechnology company focused on developing innovative therapies and solutions in the field of vaccine development and infectious disease management. The company specializes in research and development aimed at enhancing vaccine efficacy and safety, leveraging advanced technologies to address global health challenges. Sanrovax is committed to improving public health outcomes through its scientific expertise and collaborative partnerships within the healthcare sector.